Related Experiment Videos
[Primary enuresis in children. Which treatment today?]
Minerva Pediatrica
|October 1, 1994
Summary
Pediatric enuresis affects many school-aged children. Desmopressin (DDAVP) and acupuncture show promise in reducing wet nights, with long-term success rates of 50% and 40% respectively.
Area of Science:
- Pediatric Urology
- Sleep Medicine
- Complementary Medicine
Background:
- Enuresis affects 15-30% of school-aged children, often as monosymptomatic nocturnal enuresis.
- The multifactorial pathophysiology includes genetic, psychological, sleep, and urinary factors, making treatment controversial.
- Current treatments like behavioral therapy and pharmacotherapy yield variable results.
Purpose of the Study:
- To evaluate the efficacy of Desmopressin (DDAVP) and acupuncture in treating pediatric enuresis.
- To compare short-term and long-term success rates of DDAVP and acupuncture.
- To discuss the pathophysiology of enuresis and the importance of patient selection.
Main Methods:
- A retrospective analysis of 54 enuretic children treated over one year.
- Assessment of treatment effectiveness based on the reduction in wet nights per week.
- Evaluation of short-term and long-term success rates for DDAVP and acupuncture therapies.
Main Results:
- DDAVP reduced wet nights by 79% in the short term.
- Acupuncture yielded good results in 55% of treated patients.
- Long-term success rates were 50% for DDAVP and 40% for acupuncture.
Conclusions:
- DDAVP and acupuncture are effective treatment options for pediatric enuresis.
- Accurate patient selection and understanding pathophysiology are crucial for successful enuresis management.
- Further research into the multifactorial causes of enuresis is warranted.